Document:

EXHIBIT 10.4
                         Aholt Stock Purchase Agreement

                                                                    Exhibit 10.4

Phase III Medical, Inc.

SUBSCRIPTION AGREEMENT

      This SUBSCRIPTION AGREEMENT (this "Agreement"), dated as of September 13,
2004, is by and between Phase III Medical, Inc., a Delaware corporation (the
"Company"), and Aholt Jr. Family Trust dated 2/17/97 (the "Investor").

      WHEREAS, the Company desires to issue and sell to the Investor, and the
Investor desires to purchase from the Company, shares of common stock, $0.001
par value per share, of the Company (the "Common Stock"), upon and subject to
the terms and conditions hereinafter set forth.

      NOW THEREFORE, in consideration of the foregoing recitals and the mutual
covenants and agreements of the parties set forth in this Agreement, and for
other good and valuable consideration, the receipt and sufficiency of which are
acknowledged, the parties agree as follows:

      1. Purchase and Sale of the Shares.

            1.1. Agreement to Sell and Purchase Shares. Subject to the terms and
conditions hereof, the Company agrees to issue and sell to the Investor and the
Investor agrees to purchase from the Company, at the Closing (as defined below),
an aggregate of 7,282,913(1) shares of Common Stock (the "Shares"), for an
aggregate purchase price of $650,000 (the "Purchase Price"), payable in
immediately available funds at the Closing.

            1.2. Delivery of Shares; Legend.

                  (a) As soon as reasonably practicable after the Closing, the
Company shall deliver to the Investor one or more certificates, registered in
the name of the Investor, representing the Shares. Delivery of certificates
representing the Shares shall be made against receipt by the Company of a check
payable to the order of the Company or a wire transfer of U.S. funds to an
account designated by the Company in the full amount of the Purchase Price.

----------
(1) The aggregate number of shares shall be equal to the quotient of $650,000
divided by the Per Share Purchase Price. The Per Share Purchase Price shall be
equal to 85% of the average of the closing price of one share of Common Stock on
the NASD Over-The-Counter Bulletin Board for the five (5) days immediately
preceding the date of this Agreement. Notwithstanding the foregoing, the Per
Share Purchase Price shall not be more than $0.10 per share nor less than $0.085
per share.

<PAGE>

                  (b) The certificates representing the Shares delivered
pursuant to Section 1.2(a), and any securities issued in exchange for or in
respect thereof, shall bear a legend to the following effect.

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES
LAWS OF ANY STATE AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE
STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH STATE SECURITIES LAWS."

            1.3. Closing. The closing (the "Closing") of the transactions
contemplated by this Agreement shall take place on the date hereof at the
offices of the Company.

            1.4 Additional Purchase/Conversion of Note. The Investor has also
loaned to the Company on or about August 30, 2004 the sum of $100,000 pursuant
to a six month promissory note bearing interest at 20% per annum (the "Note").
The Investor and the Company hereby irrevocably agree that upon the Maturity of
that Note, the Company shall repay the Note in shares of its Common Stock, at a
conversion price equal to a per share purchase price equal to 85% of the average
of the closing price of one share of Common Stock on the NASD Over-the-Counter
Bulletin Board for the five (5) days immediately preceding the Maturity Date of
the Note, or, if the Company's Common Stock is not then traded on the OTC
Bulletin Board, at 85% of fair market value as determined by the Board of
Directors of the Company.

      2. Representations, Warranties and Covenants of the Investor.

2.1. Authorization; Enforceability. The Investor is (i) a bona fide resident of
the state contained in the address set forth on the signature page as the
Investor's home address, (ii) at least 21 years of age and (iii) legally
competent to execute this Agreement. This Agreement has been duly executed and
delivered by the Investor and, assuming the due authorization, execution and
delivery of this Agreement by the other party hereto, constitutes the legal,
valid and binding obligation of the Investor, enforceable against the Investor
in accordance with its terms, subject to the effects of any applicable
bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or
general laws of applicability affecting creditors' rights generally and to
general equitable principles.

2.2. No Conflict. The execution, delivery and performance by the Investor of
this Agreement will not result in the violation by the Investor of any law,
statute, rule, regulation, order, writ, injunction, judgment or decree of any
court or governmental authority to or by which the Investor is bound, and will
not conflict with, or result in a breach or violation of, any of the terms or
provisions of, or constitute (with due notice or lapse of time or both) a
default under, any lease, loan agreement, mortgage, security agreement, trust
indenture or other agreement or instrument to which the Investor is a party or
by which he is bound or to which any of his properties or assets is subject.

<PAGE>

2.3. Governmental Consents. No consent, approval, authorization or other order
of any governmental authority or other third party is required to be obtained by
the Investor in connection with the authorization, execution, delivery and
performance by the Investor of this Agreement.

2.4. Investment Representations.

                  (a) The Investor hereby represents and warrants to the Company
that the Investor is an "accredited investor" as that term is defined in Rule
501(a) of Regulation D promulgated under the Securities Act of 1933, as amended
(the "Securities Act"). Specifically, the Investor certifies that (initial all
appropriate spaces on the following pages):

                    _________ (1) The Investor is an accredited investor because
                    (Initial) he has an individual net worth, or with his spouse
                              has a joint net worth, in excess of $1,000,000.
                              For purposes of this Agreement, "net worth" means
                              the excess of total assets at fair market value,
                              including home, home furnishings and automobiles,
                              over total liabilities.

                    _________ (2) The Investor is an accredited investor because
                    (Initial) he has individual income (exclusive of any income
                              attributable to his spouse) of more than $200,000
                              in each of the past two years, or joint income
                              with his spouse in excess of $300,000 in each of
                              those years, and such investor reasonably expects
                              to reach the same income level in the current
                              year.

                    _________ (3) The Investor is an accredited investor because
                    (Initial) he is a director, executive officer or managing
                              member of the Company.

                  (b) The Investor hereby certifies that he is not a
non-resident alien for purposes of income taxation (as such term is defined in
the Internal Revenue Code of 1986, as amended, and Income Tax Regulations). The
Investor hereby agrees that if any of the information in this Section 2.4(b)
changes, the Investor will notify the Company within 60 days thereof. The
Investor understands that the information contained in this Section 2.4(b) may
be disclosed to the Internal Revenue Service by the Company and that any false
statement contained in this Section 2.4(b) could be punished by fine,
imprisonment or both.

      (c) The Investor will not sell or otherwise transfer the Shares without
registration under the Securities Act or an exemption therefrom, and fully
understands and agrees that he must bear the economic risk of his investment for
an indefinite period of time because, among other reasons, the Shares have not
been registered under the Securities Act or under the securities laws of certain
states and, therefore, cannot be resold, pledged, assigned or otherwise disposed
of unless they are subsequently registered under the Securities Act and under
applicable securities laws of such states or an exemption from such registration
is

<PAGE>

available. The Investor understands that the Company is under no obligation to
register the Shares on his behalf or to assist him in complying with any
exemption from such registration under the Securities Act, except that if any
sale proposed by the Investor is exempt from registration, the Company will
cause its counsel, at the Company's expense, to provide an appropriate opinion
to that effect to the Company's transfer agent. It also understands that sales
or transfers of the Shares are further restricted by state securities laws. The
Investor further understands that the Company is not registered as an investment
company under the Investment Company Act of 1940, as amended.

      (d) The Investor acknowledges that in making a decision to subscribe for
the Shares, the Investor has relied solely upon independent investigations made
by the Investor. The Investor understands the business objectives and policies
of, and the strategies which may be pursued by, the Company. The Investor's
investment in the Shares is consistent with the investment purposes and
objectives and cash flow requirements of the Investor and will not adversely
affect the Investor's overall need for diversification and liquidity. The
Investor acknowledges that he is not subscribing pursuant hereto for any Shares
as a result of or subsequent to (a) any advertisement, article, notice or other
communications published on-line, in any newspaper, magazine or similar media or
broadcast over television or radio, or (b) any seminar or meeting whose
attendees, including the Investor, had been invited as a result of, subsequent
to or pursuant to any of the foregoing.

      (e) The Investor has not reproduced, duplicated or delivered this
Agreement to any other person, except professional advisors to the Investor or
as instructed by the Company.

      (f) The Investor has such knowledge and experience in financial and
business matters that the Investor is capable of evaluating the merits and risks
of the Investor's investment in the Shares and is able to bear such risks, and
has obtained, in the Investor's judgment, sufficient information from the
Company or its authorized representatives to evaluate the merits and risks of
such investment. The Investor has evaluated the risks of investing in the Shares
and has determined that the Shares is a suitable investment for the Investor.

      (g) The Investor can afford a complete loss of the investment in the
Shares, can afford to hold the investment in the Shares for an indefinite period
of time, and acknowledges that distributions may be paid in cash or in kind.

      (h) The Investor's overall commitment to investments that are not readily
marketable is not disproportionate to his net worth, and his investment in the
Shares will not cause such overall commitment to become excessive.

      (i) The Investor has adequate means of providing for his current needs and
contingencies and has no need for liquidity in its investment in the Shares.

      (j) The Investor is acquiring the Shares subscribed for herein for his own
account, for investment purposes only and not with a view to distribute or
resell such Shares in whole or in part.

<PAGE>

      (k) The Investor agrees and is aware that:

(1) the Company has a limited operating history under its current business plan;

(2) no federal or state agency has passed upon the Shares or made any findings
or determination as to the fairness of this investment;

(3) there are substantial risks of loss of investment incidental to the purchase
of the Shares; and

(4) the Shares cannot be resold readily because the Shares have not been
registered by the Securities and Exchange Commission and the Shares cannot be
resold without (A) the Company's consent, which may require an effective
registration statement, or (B) an opinion of counsel that an exemption of
registration is available, and the Investor may have to bear the risk of this
investment for an indefinite period of time.

      (l) The Investor and its advisors, if any, have been furnished with all
materials relating to the business, finances and operations of the Company and
materials relating to the offer and sale of the Shares, which have been
requested by the Investor. The Investor and his advisors, if any, have been
afforded the opportunity to ask questions of the Company and have received
complete and satisfactory answers to any such inquiries. The Investor has had
access to all additional information necessary to verify the accuracy of the
information set forth in this Agreement and any other materials furnished
herewith, and has taken all the steps necessary to evaluate the merits and risks
of an investment as proposed hereunder. Except as set forth in this Agreement,
the Company has made no representation or warranty on which the Investor has
relied to enter into this Agreement and acquire the Shares.

      (m) The Investor does not have a present intention to sell the Shares nor
a present arrangement or intention to effect any distribution of any of the
Shares to or through any person or entity for purposes of selling, offering,
distributing or otherwise disposing of any of the Shares.

      (n) The Investor understands that the legend set forth in Section 1.2(b),
to the effect that the Shares have not been registered under the Securities Act
or applicable state securities laws, shall be placed on the certificate
evidencing the Shares and appropriate notations to such effect will be made in
the Company's stock books.

                  (o) The Investor understands that the net proceeds to the
Company from this subscription will be used by the Company for general operating
expenses.

            2.5. Brokers. There is no broker, investment banker, financial
advisor, finder or other person which has been retained by or is authorized to
act on behalf of the Investor who is entitled to any fee or commission in
connection with the execution of this Agreement.

      3. Indemnification. The Investor agrees to indemnify and hold harmless the
Company, and its managers, officers, directors, employees, agents and
shareholders, and each other person, if any, who controls or is controlled by,
within the meaning of Section 15

<PAGE>

of the Securities Act, any thereof, against any and all loss, liability, claim,
damage, cost and expense whatsoever (including, but not limited to, legal fees
and disbursements and any and all other expenses whatsoever incurred in
investigating, preparing for or defending against any litigation, arbitration
proceeding, or other action or proceeding, commenced or threatened, or any claim
whatsoever) arising out of or in connection with, or based upon or resulting
from, (a) any false representation or warranty or breach or failure by the
Investor to comply with any covenant or agreement made by the Investor in this
Agreement or in any other document furnished by the Investor to any of the
foregoing in connection with this transaction or (b) any action for securities
law violations instituted by the Investor which is finally resolved by judgment
against the Investor.

      4. Power of Attorney. The Investor, as a shareholder of the Company,
hereby appoints the Company as its true and lawful representative and
attorney-in-fact, in its name, place and stead to make, execute, sign,
acknowledge, swear to and file:

(a) any Company certificate, business certificate, fictitious name certificate,
amendment thereto, or other instrument or document of any kind necessary or
desirable to accomplish the business, purpose and objectives of the Company, or
required by any applicable federal, state, or local or foreign law; and

(b) any and all instruments, certificates and other documents which may be
deemed necessary or desirable to effect the winding-up and termination of the
Company (including, but not limited to, a notice of dissolution of the
Shareholder).

This power of attorney is coupled with an interest, is irrevocable, and shall
survive and shall not be affected by the subsequent death, disability,
incompetency, termination, bankruptcy, insolvency or dissolution of the
Investor; provided, however, that this power of attorney will terminate upon the
substitution of another shareholder of the Company for the Investor, upon the
withdrawal of the Investor from the Company or upon the redemption of all of the
Shares owned by the Investor.

      5. Miscellaneous.

            5.1. Notices. All notices, demands and other communications to be
given or delivered under or by reason of the provisions of this Agreement shall
be in writing and shall be deemed to have been given when delivered personally
or when mailed by certified or registered mail, return receipt requested and
postage prepaid, and addressed to the address of such party set forth below or
to such changed address as such party may have fixed by written notice to the
other given in accordance with this Section 5.1; provided, however, that any
notice of change of address shall be effective only upon receipt:

If to the Company:

Phase III Medical, Inc.
330 South Service Road, Suite 120
Melville, NY 11747
Attn: Mark Weinreb, President and CEO

<PAGE>

If to the Investor:

the same address as indicated on the signature page hereto.

            5.2. Entire Agreement; Amendment. This Agreement sets forth the
entire agreement and understanding between the parties as to the subject matter
hereof and merges and supersedes all prior discussions, agreements and
understandings of any and every nature among them. This Agreement may be amended
only by mutual written agreement of the Company and the Investor. No course of
dealing between or among any persons having any interest in this Agreement will
be deemed effective to modify, amend or discharge any part of this Agreement or
any rights or obligations of any person under or by reason of this Agreement.

            5.3. Successors and Assigns. This Agreement shall be binding upon
the Investor and his heirs, legal representatives, successors, and permitted
assigns and shall inure to the benefit of the Company and its successors and
assigns. The Investor shall not assign any of its obligations hereunder without
the prior written consent of the Company.

            5.4. Governing Law. This Agreement shall be governed by and
construed under the laws of the State of New York without regard to its choice
of law provisions.

            5.5. Jurisdiction. The Investor hereby irrevocably agrees that any
suit, action or proceeding with respect to this Agreement and any or all
transactions relating hereto and thereto may be brought in U.S. federal and
state courts in the State of New York. The Investor hereby irrevocably submits
to the jurisdiction of such courts with respect to any such suit, action or
proceeding and agrees and consents that service of process as provided by U.S.
federal and New York law may be made upon the Investor in any such suit, action
or proceeding brought in any of said courts, and may not claim that any such
suit, action or proceeding has been brought in an inconvenient forum. The
Investor hereby further irrevocably consents to the service of process out of
any of the aforesaid courts, in any such suit, action or proceeding, by the
mailing of copies thereof, by certified or registered mail, return receipt
requested, addressed to the Investor at the address of the Investor then
appearing on the records of the Company. Nothing contained herein shall affect
the right of the Company to commence any action, suit or proceeding or otherwise
to proceed against the Investor in any other jurisdiction or to serve process
upon the Investor in any manner permitted by any applicable law in any relevant
jurisdiction.

            5.6. Additional Information and Subsequent Changes to
Representations.

                  (a) The Company may request from time to time such information
as it may deem necessary to determine the eligibility of the Investor to hold
Stock or to enable the Company's compliance with applicable regulatory
requirements or tax status, and the Investor shall provide such information as
may reasonably be requested.

      (b) The Investor agrees to notify the Company promptly if there is any
change with respect to any of the information or representations given or made
by the Company pursuant to this Agreement and to provide the Company with such
further information as the Company may reasonably require. In addition, the
Investor agrees that at any time in the

<PAGE>

future at which the Investor may acquire additional shares of Common Stock, the
Investor shall be deemed to have reaffirmed, as of the date of such acquisition
of additional shares of Common Stock, each and every representation made by the
Investor in this Agreement, except to the extent modified in writing by the
Investor and consented to by the Company.

5.7. Severability. In the event that any provision of this Agreement or the
application of any provision hereof is declared to be illegal, invalid or
otherwise unenforceable by a court of competent jurisdiction, the remainder of
this Agreement shall not be affected except to the extent necessary to delete
such illegal, invalid or unenforceable provision unless the provision held
invalid shall substantially impair the benefit of the remaining portion of this
Agreement.

5.8. Headings. The headings of the sections hereof are inserted as a matter of
convenience and for reference only and in no way define, limit or describe the
scope of this Agreement or the meaning of any provision hereof.

            5.9. Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed to be
an original and all of which together shall be deemed to be one and the same
agreement. A facsimile transmission of this signed Agreement shall be legal and
binding on all parties hereto to the same extent as if delivered personally.

[Signature Pages Follow]

<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the date set forth above under penalties of perjury.

COMPANY:

PHASE III MEDICAL, INC.

By:
   ---------------------------------
Name:
Title:

INVESTOR:

------------------------------------
Robert Aholt, Jr. Trustee
Aholt Jr. Family Trust dated 2/17/97

Address: 20128 Cavern Court
Saugus, California 91390

Tax I.D. Number:  xxx-xx-xxxxEXHIBIT 10.5
Aholt Promissory Note

                                                             Exhibit 10.5

THIS PROMISSORY  NOTE HAS NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF 1933,
AS  AMENDED.  THE  NOTE  HAS  BEEN  ACQUIRED  FOR  INVESTMENT  AND  MUST BE HELD
INDEFINITELY and MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS IT
IS SUBSEQUENTLY  REGISTERED  UNDER SAID ACT or, in the opinion of counsel to the
company, an exemption from registration under said act is available.

PROMISSORY NOTE

$100,000                                                        August 30, 2004

FOR VALUE RECEIVED,  Phase III Medical, Inc., a Delaware corporation,  ("Maker")
promises to pay to Robert Aholt ("Payee"),  in lawful money of the United States
of America,  the principal sum of One Hundred Thousand  Dollars  ($100,000.00 ),
together with interest  thereon  accruing at an annual rate equal to 20%, in the
manner  provided  below.  Interest shall be calculated on the basis of a year of
365 or 366 days,  as  applicable,  and  charged  for the  actual  number of days
elapsed.

1.    PAYMENTS

      1.1   Principal and interest.

            Interest on the unpaid  principal amount shall be payable monthly in
            arrears until the entire principal amount shall be paid in full. All
            principal and accrued interest shall be paid in full on February 30,
            2005 (6 months after the date of issuance of this Note).

      1.2   Manner of Payment

            All payments of principal and interest on this Note shall be made by
            check at Robert Aholt, 20128 Cavern Court,  Saugus, CA, 91390, or at
            such  other  place in the United  States of  America as Payee  shall
            designate  to Maker in  writing.  If any  payment  of  principal  or
            interest  on this Note is due on a day which is not a

<PAGE>

            Business  Day,  such  payment  shall be due on the  next  succeeding
            Business  Day.  "Business  Day" means any day other than a Saturday,
            Sunday or legal holiday in the State of New York.

      1.3   Prepayment

            Maker may, without premium or penalty,  at any time and from time to
            time, prepay all or any portion of the outstanding principal balance
            due  under  this  Note,   provided  that  each  such  prepayment  is
            accompanied by accrued  interest on the amount of principal  prepaid
            calculated to the date of such prepayment.

            Any partial  prepayments  shall be applied first to accrued interest
            and then to principal.

2.    DEFAULTS

      2.1   Events of Default

            The  occurrence  of any  one or more of the  following  events  with
            respect to Maker  shall  constitute  an event of  default  hereunder
            ("Event of Default"):

            (a)   If Maker shall fail to pay when due any  payment of  principal
                  or interest on this Note.

            (b)   If,  pursuant  to or within the  meaning of the United  States
                  Bankruptcy  Code or any other federal or state law relating to
                  insolvency or relief of debtors (a  "Bankruptcy  Law"),  Maker
                  shall  (i)  commence  a  voluntary  case or  proceeding;  (ii)
                  consent to the entry of an order for  relief  against it in an
                  involuntary  case;  (iii)  consent  to  the  appointment  of a
                  trustee, receiver,  assignee,  liquidator or similar official;
                  (iv) make an assignment for the benefit of its  creditors;  or
                  (v) admit in writing  its  inability  to pay its debts as they
                  become due.

            (c)   If a court of competent jurisdiction enters an order or decree
                  under any  Bankruptcy Law that (i) is for relief against Maker
                  in an involuntary case; (ii) appoints of a trustee,  receiver,
                  assignee,  liquidator  or  similar  official  for the Maker or
                  substantially all of the Maker's  properties;  or (iii) orders
                  the  liquidation  of the Maker,  and in each case the order is
                  not dismissed within 90 days.

      2.2   Remedies

            Upon the  occurrence  of an Event of Default  hereunder  (unless all
            Events of Default have been cured or waived by Payee), Payee may, at
            its  option,  (i) by  written  notice to Maker,  declare  the entire
            unpaid  principal  balance of this Note,  together  with all accrued
            interest thereon, immediately due and payable, and (ii) exercise all
            and any rights and remedies  available to it under  applicable  law,
            including,  without limitation,  the right to collect from maker all
            sums due under

<PAGE>

            this  Note.  Maker  shall  pay all  reasonable  costs  and  expenses
            incurred  by or on  behalf  of  Payee  in  connection  with  Payee's
            exercise of any or all of its rights and  remedies  under this Note,
            including,  without  limitation,   reasonable  attorneys'  fees  and
            expenses.

3.    REPRESENTATIONS BY PAYEE

      Payee represents and warrants to Maker as follows:

      (a)   Payee has received and examined all information, including financial
            statements,  of or concerning Maker which Payee considers  necessary
            to making an informed  decision  regarding  this Note.  In addition,
            Payee has had the  opportunity  to ask  questions  of,  and  receive
            answers from, the officers and agents of Maker  concerning Maker and
            to obtain such information, to the extent such persons possessed the
            same or could acquire it without  unreasonable effort or expense, as
            Payee deemed  necessary  to verify the  accuracy of the  information
            referred to herein.

      (b)   The Payee  acknowledges  and understands that (i) the Maker will use
            the proceeds of this Note in its the  establishment  of new business
            operations; (ii) the proceeds of this Note will not be sufficient to
            provide  Maker  with the  necessary  funds to  achieve  its  current
            business  plan;  (iii)  the  Maker  does  not have  sufficient  cash
            available to repay this Note;  (iv) this Note will not be guaranteed
            nor will it be  secured  by any  assets of Maker  nor  senior to any
            other  indebtedness of Maker;  and (v) Payee bears the economic risk
            of never being repaid on this Promissory Note.

      (c)   The Payee hereby  certifies that Payee is an  "Accredited  Investor"
            (as that term is defined by Regulation D under the Securities Act of
            1933, as amended)  because at least one of the following  statements
            is applicable to Payee:

                  (i)   Payee is an  Accredited  Investor  because the Payee had
                        individual  income of more than  $200,000 in each of the
                        two prior calendar years and reasonably  expects to have
                        individual  income  in  excess of  $200,000  during  the
                        current calendar year.

                  (ii)  The Payee is an  Accredited  Investor  because the Payee
                        and his spouse together had income of more than $300,000
                        in each of the two prior  calendar  years and reasonably
                        expect to have joint income in excess of $300,000 during
                        the current calendar year.

                  (iii) The Payee is an  Accredited  Investor  because the Payee
                        has an individual net worth, or the Payee and his spouse
                        have a joint net worth of more than $1,000,000.

      (d)   Payee is  acquiring  this Note for his own account,  for  investment
            purposes only, and not with a view to the resale or  distribution of
            all or any part thereof.

      (e)   Payee  acknowledges that this Note (i) has not been registered under
            applicable  securities laws, (ii) will be a "restricted security" as
            defined in  applicable  securities  laws,  (iii) has been  issued in
            reliance on the statutory exemptions from registration  contemplated
            by  applicable  securities  laws based (in part) on the  accuracy of
            Payee's  representations  contained  herein,  and  (iv)  will not be
            transferable without registration under applicable  securities laws,
            unless  an  exemption  from  such   registration   requirements   is
            available.

<PAGE>

      (f)   Payee has reviewed and understands Maker's (i) Annual Report on Form
            10-K for the fiscal year ended  December  31, 2003;  (ii)  Quarterly
            Reports  on  Form10-Q  for the  quarters  ended  March 31,  June 30,
            September  30,  2003,  and  March 31,  June 30,  2004;  (iii)  proxy
            statement for its 2003 annual meeting of  shareholders  and (iv) all
            Current  Report on Form 8-K filed  since the filing of its last Form
            10-K.

4.    MISCELLANEOUS

      4.1   Waiver

            The rights and remedies of Payee under this Note shall be cumulative
            and not alternative. No waiver by Payee of any right or remedy under
            this Note shall be  effective  unless it is in writing and signed by
            Payee.  Neither the failure nor any delay in  exercising  any right,
            power or privilege  under this Note will operate as a waiver of such
            right,  power or privilege and no single or partial  exercise of any
            such right,  power or privilege by Payee will  preclude any other or
            further  exercise of such right,  power or privilege or the exercise
            of any  other  right,  power or  privilege.  To the  maximum  amount
            permitted by applicable  law, (i) no claim or right of Payee arising
            out of this Note can be discharged by Payee, in whole or in part, by
            a waiver or  renunciation of the claim or right unless in a writing,
            signed by Payee;  (b) no waiver  that may be given by Payee  will be
            applicable  except in the  specific  instance for which it is given;
            and (c) no  notice  to or  demand  on Maker  will be  deemed to be a
            waiver of any  obligation  of Maker or of the right of Payee to take
            further action without notice or demand as provided in this Note.

            Maker acknowledges that this Note and Maker's obligations under this
            Note are,  and  shall at all  times  continue  to be,  absolute  and
            unconditional  in all respects,  and shall at all times be valid and
            enforceable. To the extent permitted by applicable law, Maker hereby
            absolutely,  unconditionally  and irrevocably forever waives any and
            all right to assert any  defense,  set-off,  off-set,  counterclaim,
            cross-claim,  or claim of any nature whatsoever with respect to this
            Note or Maker's obligations hereunder.

      4.2   Notices

            Any notice or  communication  to be given hereunder by any party, to
            the other party shall be in writing and shall be deemed to have been
            given when personally  delivered,  or one day after the date sent by
            recognized  overnight  courier or  transmitted  by facsimile,  which
            transmission by facsimile has been confirmed or 3 (three) days after
            the date sent by registered or certified mail,  postage prepaid,  as
            follows:

<PAGE>

                  If to Maker, addressed to it at:

                  Phase III Medical, Inc.
                  330 South Service Road
                  Suite 120
                  Melville, NY 11747
                  Attn: Mark Weinreb
                  Facsimile Number: (631) 574 4956

                  If to Payee, addressed to:

                  Name: Robert Aholt
                  Address: 20128 Cavern Court
                           Saugus, CA  91390

            Or persons or addresses as may be designated in writing by the party
            to receive such notice.

      4.3   Severability

            If any  provision of this Note is held invalid or  unenforceable  by
            any court of competent  jurisdiction,  the other  provisions of this
            Note will remain in full force and  effect.  Any  provision  of this
            Note held  invalid  or  unenforceable  only in part or  degree  will
            remain in full force and  effect to the  extent not held  invalid or
            unenforceable.

      4.4   Governing Law.

            This  Promissory  Note will be  governed by the laws of the State of
            New York without regard to conflicts of laws principles.

      4.5   Assignment; Parties in Interest

            This Note shall bind Maker and its successors and assigns. This Note
            shall not be assigned or transferred  by Maker,  without the express
            prior  written  consent  of Payee,  and this Note will  inure to the
            benefit   of  Payee  and  his   heirs,   estates,   representatives,
            administrators, successors and assigns.

      4.6   Section Headings, Construction

            The headings of Sections in this Note are  provided for  convenience
            only and will not affect its  construction  or  interpretation.  All
            references  to "Section" or  "Sections"  refer to the  corresponding
            Section or Sections of this Note unless otherwise specified.

<PAGE>

            All words used in this Note will be  construed  to be of such gender
            or number as the circumstances  require.  Unless otherwise expressly
            provided,  the words "hereof" and "hereunder" and similar references
            refer to this Note in its entirety  and not to any specific  section
            or subsection hereof.

      4.7   Savings Clause

            If, at any  time,  the rate of  interest  under  this Note  shall be
            deemed  by any  competent  court  of  law,  governmental  agency  or
            tribunal to exceed the maximum  rate of  interest  permitted  by the
            laws of any applicable  jurisdiction  or the rules or regulations of
            any  regulatory  authority or agency,  then during such time as such
            rate of interest  would be deemed  excessive,  that  portion of each
            interest payment  attributable to that portion of such interest rate
            that  exceeds the maximum  rate of  interest so  permitted  shall be
            deemed a voluntary  prepayment of principal or, if all principal has
            been paid,  that portion of each interest  payment  attributable  to
            that portion of such  interest rate that exceeds the maximum rate of
            interest so permitted shall be promptly refunded to Maker.

      4.8   Waiver of Jury Trial

            MAKER AND PAYEE EACH HEREBY WAIVE,  TO THE FULLEST EXTENT  PERMITTED
            BY  APPLICABLE  LAW,  ANY  RIGHT  IT MAY  HAVE TO A TRAIL BY JURY IN
            RESPECT OF ANY  LITIGATION  DIRECTLY OR  INDIRECTLY  ARISING OUT OF,
            UNDER,  OR IN CONNECTION  WITH,  THIS NOTE, IT BEING AGREED THAT ALL
            SUCH TRAILS  SHALL BE CONDUCTED  SOLELY BY A JUDGE.  MAKER AND PAYEE
            EACH CERTIFY THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF EITHER HAS
            REPRESENTED,  EXPRESSLY OR  OTHERWISE,  THAT THE OTHER WOULD NOT, IN
            THE EVENT OF  LITIGATION,  SEEK TO ENFORCE  THE  FOREGOING  WAIVERS.
            MAKER  AND  PAYEE  EACH  AGREE  AND  ACKNOWLEDGE  THAT  IT HAS  BEEN
            REPRESENTED BY INDEPENDENT  COUNSEL IN CONNECTION  WITH THIS NOTE OR
            BEEN ADVISED THAT IT SHOULD BE REPRESENTED BY INDEPENDENT COUNSEL IN
            CONNECTION  WITH THIS NOTE.  IF MAKER OR PAYEE HAS DECIDED NOT TO BE
            REPRESENTED BY INDEPENDENT  COUNSEL IN CONNECTION WITH THIS NOTE, IT
            IRREVOCABLY  AND  FOREVER  WAIVES  ANY AND ALL  DEFENSES  OR  RIGHTS
            ARISING OUT OF OR RELATED TO SAID DECISION.

<PAGE>

IN WITNESS  WHEREOF,  Maker has executed and delivered  this Note as of the date
first stated above.

PHASE III MEDICAL, INC.

                                    Bye :
                                         --------------------------------
                                    Name: Mark Weinreb
                                    Title: President and Chief Executive Officer

Accepted and agreed to:

-----------------------------------
Payee: Robert Aholt

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]